Skip to main content

Table 5 Prevalence of participants with abnormal and clinically significant findings following clinical investigations. Descriptive data detailing the total number in each group and percentage based on the number of tests performed

From: Cardiopulmonary, Functional, Cognitive and Mental Health Outcomes Post-COVID-19, Across the Range of Severity of Acute Illness, in a Physically Active, Working-Age Population

 

H

CS

CR

COM

CT

 Tests performed

34

34

18

0

 Abnormal result

20 (58%)

2 (6%)

2 (11%)

–

 Clinically significant

2 (6%)

0 (0%)

0 (0%)

–

CTPA

 Tests performed

32

34

18

0

 Abnormal result

8 (25%)

1 (3%)

0 (0%)

–

 Clinically significant

0 (0%)

0 (0%)

0 (0%)

–

CMR

 Tests performed

35

34

18

26

 Abnormal result

4 (11%)

5 (15%)

3 (17%)

1 (4%)

Clinically significant

0 (0%)

0 (0%)

0 (0%)

0 (0%)

  1. Abbreviations: CT, computerised tomography; CTPA, computerised tomography pulmonary angiogram; CMR, cardiovascular magnetic resonance imaging. H, hospitalised illness; CS, community illness with on-going symptoms (community-symptomatic), CR, community illness now recovered (community-recovered; COM age-, gender- and job-role-matched comparison population